Cholinesterase inhibitors

Parasympathomimetics/Cholinergic agonists

by
parasympathomimetics

Introduction Parasympathomimetics — also referred to as cholinergic agonists or muscarinic agonists—are a class of medications that enhance or mimic the actions of the parasympathetic nervous system (PNS). The PNS is one subdivision of the autonomic nervous system, often described as the “rest and digest” branch. Through stimulation of acetylcholine (ACh) receptors, parasympathomimetics elicit various physiological responses such … Read more

Alzheimer’s Disease and treatment

by
alzheimers disease

Alzheimer’s disease is a progressive neurodegenerative disorder marked by amyloid and tau protein pathology that leads to gradual decline in memory, function, and behavior; management combines accurate staging, symptomatic cognitive therapies, comprehensive non‑pharmacologic care, and, in eligible early cases, disease‑modifying anti‑amyloid monoclonal antibodies with structured MRI safety monitoring. Evidence‑based symptomatic options include acetylcholinesterase inhibitors and … Read more